Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Preffer

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Lancet (London, England)|May 29, 1999
Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationM Sykes, F Preffer, S McAfee, et al.
Transplantation|February 12, 1999
In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipientsH Vallhonrat, W W Williams, A B Cosimi, et al.
Bone Marrow Transplantation|July 1, 2008
Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCTD T Ting, T R Spitzer, A Chaudhary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignanciesT R Spitzer, S McAfee, R Sackstein, et al.
Bone Marrow Transplantation|May 1, 2007
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimenB R Dey, J Shaffer, A J Yee, et al.
Transplantation|August 10, 2000
Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primatesT Kawai, S L Wee, H Bazin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2011
Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantationG Andreola, M Chittenden, J Shaffer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 27, 2006
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analysesY Fudaba, T R Spitzer, J Shaffer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 7, 2014
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppressionT Kawai, D H Sachs, B Sprangers, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Lancet (London, England)|May 29, 1999
Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantationM Sykes, F Preffer, S McAfee, et al.
Transplantation|February 12, 1999
In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipientsH Vallhonrat, W W Williams, A B Cosimi, et al.
Bone Marrow Transplantation|July 1, 2008
Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCTD T Ting, T R Spitzer, A Chaudhary, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignanciesT R Spitzer, S McAfee, R Sackstein, et al.
Bone Marrow Transplantation|May 1, 2007
Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimenB R Dey, J Shaffer, A J Yee, et al.
Transplantation|August 10, 2000
Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primatesT Kawai, S L Wee, H Bazin, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 8, 2011
Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantationG Andreola, M Chittenden, J Shaffer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 27, 2006
Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analysesY Fudaba, T R Spitzer, J Shaffer, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|June 7, 2014
Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppressionT Kawai, D H Sachs, B Sprangers, et al.
Pageof 3